Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus P Schneider

Showing results (1-10 of 107) with videos related to

Pageof 11
Sort By:
Journal of Hypertension|September 14, 2012
Role of neuroendocrine activation for left ventricular hypertrophy in hypertensionMarkus P Schneider, Roland E Schmieder
Hypertension (Dallas, Tex. : 1979)|June 28, 2006
Clarifying endothelin type B receptor functionDavid M Pollock, Markus P Schneider
Deutsche Medizinische Wochenschrift (1946)|June 5, 2019
[Risk Scores in Patients with Chronic Kidney Disease]Markus P Schneider, Kai-Uwe Eckardt
MMW Fortschritte Der Medizin|January 22, 2003
[Left ventricular hypertrophy. Recent aspects of diagnosis and therapy]Roland E Schmieder, Markus P Schneider
Hypertension (Dallas, Tex. : 1979)|November 23, 2016
Specific Aldosterone Synthase Inhibition: A Potential Improvement Over Mineralocorticoid Receptor Antagonism?Markus P Schneider, Karl F Hilgers
Deutsche Medizinische Wochenschrift (1946)|August 30, 2017
[How to Retard Progression of Chronic Kidney Disease]Markus P Schneider, Karl F Hilgers
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 5, 2014
Endothelin antagonism for patients with chronic kidney disease: still a hope for the futureMarkus P Schneider, Johannes F Mann
Journal of Hypertension|May 21, 2009
Risk prediction in subjects with high-normal blood pressureMarkus P Schneider, Roland E Schmieder
Current Opinion in Nephrology and Hypertension|January 10, 2014
What should be the goal blood pressure in nondiabetic chronic kidney disease?Markus P Schneider, Karl F Hilgers
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 5, 2013
Ruling out secondary causes of hypertensionChristian Ott, Markus P Schneider, Roland E Schmieder
Pageof 11

Showing results (1-10 of 107) with videos related to

Sort By:
Pageof 11
Journal of Hypertension|September 14, 2012
Role of neuroendocrine activation for left ventricular hypertrophy in hypertensionMarkus P Schneider, Roland E Schmieder
Hypertension (Dallas, Tex. : 1979)|June 28, 2006
Clarifying endothelin type B receptor functionDavid M Pollock, Markus P Schneider
Deutsche Medizinische Wochenschrift (1946)|June 5, 2019
[Risk Scores in Patients with Chronic Kidney Disease]Markus P Schneider, Kai-Uwe Eckardt
MMW Fortschritte Der Medizin|January 22, 2003
[Left ventricular hypertrophy. Recent aspects of diagnosis and therapy]Roland E Schmieder, Markus P Schneider
Hypertension (Dallas, Tex. : 1979)|November 23, 2016
Specific Aldosterone Synthase Inhibition: A Potential Improvement Over Mineralocorticoid Receptor Antagonism?Markus P Schneider, Karl F Hilgers
Deutsche Medizinische Wochenschrift (1946)|August 30, 2017
[How to Retard Progression of Chronic Kidney Disease]Markus P Schneider, Karl F Hilgers
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 5, 2014
Endothelin antagonism for patients with chronic kidney disease: still a hope for the futureMarkus P Schneider, Johannes F Mann
Journal of Hypertension|May 21, 2009
Risk prediction in subjects with high-normal blood pressureMarkus P Schneider, Roland E Schmieder
Current Opinion in Nephrology and Hypertension|January 10, 2014
What should be the goal blood pressure in nondiabetic chronic kidney disease?Markus P Schneider, Karl F Hilgers
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 5, 2013
Ruling out secondary causes of hypertensionChristian Ott, Markus P Schneider, Roland E Schmieder
Pageof 11